These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2793022)

  • 41. [Pharmacokinetics of bismuth preparations in patients with gastritis and ulcer disease].
    Raedsch R; Walter-Sack I; Weber E; Blessing J
    Klin Wochenschr; 1990 May; 68(9):488. PubMed ID: 2355728
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current therapy of Helicobacter pylori-induced chronic gastritis and/or peptic ulcer].
    Hentschel E
    Wien Klin Wochenschr; 1994; 106(17):543-6. PubMed ID: 7975668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy].
    Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; Iakovenko EP
    Sov Med; 1984; (2):100-1. PubMed ID: 6719194
    [No Abstract]   [Full Text] [Related]  

  • 45. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
    Gisbert JP; Boixeda D; Redondo C; Alvarez Baleriola I; Jiménez I; Pérez García JI; Pajares JM
    Rev Esp Enferm Dig; 1996 Apr; 88(4):259-64. PubMed ID: 9004796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
    Karita M; Morshed MG; Ouchi K; Okita K
    Am J Gastroenterol; 1994 Jul; 89(7):1032-5. PubMed ID: 8017361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eradication of Helicobacter pylori in follicular and nonfollicular gastritis.
    Mehmet S; Ozdal E; Kamil O; Beşir K; Huseyin D; Nihat A; Cigdem EY; Nusret E
    Hepatogastroenterology; 2009; 56(91-92):930-4. PubMed ID: 19621732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
    Severi C; Abdullahi M; Tari R; Vannella L; Marcheggiano A; Capoccia D; Leonetti F; Osborn J; Annibale B
    Dig Liver Dis; 2009 Aug; 41(8):555-8. PubMed ID: 19179127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 52. The treatment of Campylobacter-associated gastritis.
    McNulty CA
    Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685
    [No Abstract]   [Full Text] [Related]  

  • 53. One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori.
    Sung JJ; Chung SC; Ling TK; Yung MY; Cheng AF; Hosking SW; Li AK
    Am J Gastroenterol; 1994 Feb; 89(2):199-202. PubMed ID: 8304303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metronidazole-resistant Helicobacter pylori.
    Becx MC; Janssen AJ; Clasener HA; de Koning RW
    Lancet; 1990 Mar; 335(8688):539-40. PubMed ID: 1968548
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
    Cutler AF; Schubert TT
    Am J Gastroenterol; 1993 Sep; 88(9):1359-61. PubMed ID: 8362830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
    Kobler E; Werth B; Wüst W; Reinhart WH
    Schweiz Med Wochenschr Suppl; 1997; 89():14S-16S. PubMed ID: 9289833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
    Nilsson F; Walder M
    Lakartidningen; 1999 Feb; 96(5):460-3. PubMed ID: 10064930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Helicobacter pylori infection--current status in clinical practice and prospects].
    Malfertheiner P
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():15-9. PubMed ID: 12466998
    [No Abstract]   [Full Text] [Related]  

  • 60. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.